During the Covid pandemic, while the sale of many types of medicines increased, in both the waves one word became popular among the common people and that is immunity. The same voice was coming from everywhere that immunity should be strong to protect against corona. Due to this, Indian citizens spent 15 thousand crores on anti-viral and anti-biotics drugs, besides Favipiravir, Remdesivir and Azithromycin drugs in the last 12 months.
If you compare the purchase of immunity booster medicines purchased this year with this period of last year, then this time it was five times. Medicines have been sold more for corona or other needs. Data from the All India Organization of Chemists and Druggists shows that in the period June 2020-May 2021, the Bhariyans bought antivirals worth 1220 crores and Favipiravir, remdesivir 833 crores. 992 crore was spent for the antibiotic azithromycin, which was 38 percent more. Doxycillin sales tripled to Rs 85 crore. At the same time, the sale of anti-parastic drug Ivermectin increased 10 times and for this Rs 237 crore was spent.
The sales of immunity boosting, vitamin drugs and mineral supplements stood at Rs 14,587 crore, which is 20 percent more than last year. The sales figure of Vitamin D alone was 817 crores and it was 40 percent more. Similarly, the figure of sales of zinc supplements stood at 183 crores.
Krishnanath Munde, Associate Director, India Ratings and Research, says that this data of All India Organization of Chemists and Druggists (AIOCD) has been taken from drug stockists, it does not include the supply of medicines which companies directly to hospitals or other big health institutions. Gives direct. At the same time, the marketing president of AIOCD AWACS says that the anti-viral Favipiravir and Remdesivir were in highest demand due to the use of second wave treatment.